In his conversation with Kinara co-editor Chase Feiger, Wu outlines Ascendis’ vision for reshaping the rare disease landscape. He discusses the need to lead with empathy in the rare space, and the steps Ascendis has taken to establish a base of trust with underserved and sometimes frustrated patient communities.